effects [qlco]
SGLT2 Inhibitors [moft]
Possibly [qlco]
Normalization [resa]
Circadian Rhythm [orgf]
Blood Pressure [orgf]
Improvement [cnce]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
EMPA [resa]
REG [gngm]
Study, Outcome [resa]
Insight [menp]
therapeutic use [topp]
Sodium [bacs, elii]
Dependent [qlco]
Glucose [bacs, carb, phsu]
SGLT2 [gngm]
inhibitors [chvf]
Patients [podg]
Type 2 Diabetes [dsyn]
SGLT2 Inhibitors [moft]
Several [qnco]
effects [qlco]
Mechanism [ftcn]
Responsible [fndg]
effects [qlco]
Undetermined [idcn]
absence [qnco]
Nocturnal [tmco]
Fall [fndg]
Blood Pressure [orgf]
Dipping [fndg]
Blood Pressure [orgf]
Phenomenon [phpr]
Type 2 Diabetes [dsyn]
pathogenesis [ftcn]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
Clinical Trials [resa]
SGLT2 Inhibitors [moft]
Systolic blood pressure [clna]
3 5 [qnco]
mmHg [qnco]
Diastolic blood pressure [clna]
mmHg [qnco]
Patients [podg]
Type 2 Diabetes [dsyn]
Addition [ftcn]
animal studies [anim]
Revealed [qlco]
SGLT2 Inhibitors [moft]
enable [menp]
Blood Pressure [orgf]
Circadian Rhythm [orgf]
Dipper [bird]
Dipper [bird]
Possibly [qlco]
Improvement [cnce]
CARDIOVASCULAR [bdsy]
Patients [podg]
Type 2 Diabetes [dsyn]
SGLT2 Inhibitors [moft]
Circadian Rhythm [orgf]
Blood Pressure [orgf]
Mechanisms [ftcn]
Responsible [fndg]
SGLT2 Inhibitor [chvf]
Induced [ftcn]
Improvement [cnce]
Circadian Rhythm [orgf]
Blood Pressure [orgf]
